Digital Pathology
Proscia Nabs $50M in Funding to Support Commercialization of Digital Pathology Software
The firm said that the money will support work with OEM partners and the expanded development and integration of artificial intelligence-based tools.
Optellum, Volpara Health Partner to Market AI-Driven Breast, Lung Cancer Detection Solutions
Premium
The firms are combining forces to get their cancer screening and diagnostic platforms into more hospitals in the US.
Precision Medicine Startup Ataraxis AI Nabs $20.4M in Series Financing
Ataraxis AI will use the new funding to bring to market its first offering, Ataraxis Breast, an AI-native prognostic/predictive platform for breast cancer.
In Brief This Week: Pramana, Vanderbilt University, MeiraGTx, Tikun, Atara
News items for the week of Jan. 20, 2025.
AI-driven tools for prescreening patients, predicting responses and outcomes, and guiding patient therapy are maturing and entering the market.
Feb 29, 2024